Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$136.56

-1.63 (-1.18%)

, SNSS

Sunesis

$2.70

-0.14 (-4.93%)

16:07
12/04/17
12/04
16:07
12/04/17
16:07

Jazz Pharmaceuticals COO Russell Cox resigns, Daniel Swisher to succeed

Jazz Pharmaceuticals (JAZZ) announced the appointment of Daniel Swisher, Jr. as president and COO, effective January 3, 2018. Swisher will report to Bruce Cozadd, chairman and CEO. Russell Cox, who has served as the company's executive vice president and COO since 2014, has resigned, effective January 3, 2018, to assume the role of CEO and member of the Board of Directors at a biotherapeutic company that is focused on helping patients with acute forms of liver failure. Swisher will join Jazz Pharmaceuticals from Sunesis Pharmaceuticals (SNSS), where he currently serves as president and chief executive officer and as a member of the Board of Directors.

JAZZ

Jazz Pharmaceuticals

$136.56

-1.63 (-1.18%)

SNSS

Sunesis

$2.70

-0.14 (-4.93%)

  • 09

    Dec

  • 14

    Dec

JAZZ Jazz Pharmaceuticals
$136.56

-1.63 (-1.18%)

11/13/17
JPMS
11/13/17
NO CHANGE
Target $185
JPMS
Overweight
JPMorgan still sees 'compelling opportunity' in Jazz shares
After hosting a call with management CEO Bruce Cozadd, JPMorgan analyst Jessica Fye sees 2018 as a year of reaccelerating Xyrem growth and a strong Vyxeos launch for Jazz Pharmaceuticals. With the shares trading at 11 times her 2018 earnings estimate, Fye continues to see Jazz as a "compelling opportunity." The company poised to generate double-digit earnings growth over the next several years, the analyst tells investors in a research note.
11/10/17
11/10/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Holly Energy (HEP) reinstated with an Equal Weight at Barclays. 2. Jazz Pharmaceuticals (JAZZ) assumed with a Neutral at H.C. Wainwright. 3. TE Connectivity (TEL) initiated with an Outperform at Wells Fargo. 4. Opus Bank (OPB) initiated with an Outperform at Fig Partners. 5. Amphenol (APH) initiated with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/10/17
HCWC
11/10/17
INITIATION
Target $150
HCWC
Neutral
Jazz Pharmaceuticals assumed with a Neutral at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat assumed coverage of Jazz Pharmaceuticals with a Neutral rating and $150 price target. The analyst believes visibility for Xyrem growth is "hazy."
11/08/17
JANY
11/08/17
NO CHANGE
Target $186
JANY
Buy
Janney would be a buyer of Jazz Pharmaceuticals on post-earnings weakness
Janney Capital analyst Ken Trbovich recommends being a buyer of Jazz Pharmaceuticals shares following the company's "mixed" Q3 report, as he continues to see Jazz being excellently positioned for long-term sustainable growth given the recent launch of Vyxeos, the expected approval and launch of JZP-110 and line extensions for Xyrem. Based on reduced estimates, he lowered his fair value estimate on Jazz shares to $186 from $192, but he maintains a Buy rating on the stock.
SNSS Sunesis
$2.70

-0.14 (-4.93%)

11/21/17
11/21/17
INITIATION
Target $7

Outperform
Oppenheimer says Sunesis has defined opportunity, initiates with Outperform
As previously reported, Oppenheimer analyst Hartaj Singh started Sunesis (SNSS) with an Outperform rating and $7 price target. While AbbVie's (ABBV) ibrutinib has demonstrated a robust risk/benefit profile across many tumor types, it is becoming apparent that about 10% or more of leukemia and lymphoma patients have a mutation that leads to relapse on ibrutinib, he contends. The analyst believes Sunesis' reversible and potent BTK inhibitor SNS-062 has the ability to address this patient population, both upon relapse following ibrutinib or directly through a biomarker-driven approach.
11/20/17
OPCO
11/20/17
INITIATION
OPCO
Outperform
Sunesis initiated with an Outperform at Oppenheimer
12/14/16
CANT
12/14/16
NO CHANGE
CANT
Hold
Sunesis rating changed to Neutral from Speculative Buy at Cantor
Cantor analyst Mara Goldstein downgraded Sunesis to Neutral based on a new rating system where Neutral is consistent with a Speculative Buy rating.

TODAY'S FREE FLY STORIES

PHM

PulteGroup

$31.34

1.11 (3.67%)

06:50
04/24/19
04/24
06:50
04/24/19
06:50
Upgrade
PulteGroup rating change  »

PulteGroup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

SXC

SunCoke Energy

$8.67

0.14 (1.64%)

06:50
04/24/19
04/24
06:50
04/24/19
06:50
Hot Stocks
SunCoke Energy backs FY19 consolidated adjusted EBITDA view $265M-$275M »

Sees FY19 domestic coke…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

SNAP

Snap

$11.99

0.46 (3.99%)

06:49
04/24/19
04/24
06:49
04/24/19
06:49
Upgrade
JPMorgan, more encouraged after Q1 results, upgrades Snap to Neutral »

JPMorgan analyst Doug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$176.83

3.82 (2.21%)

06:49
04/24/19
04/24
06:49
04/24/19
06:49
Hot Stocks
Lululemon launches strategic five-year growth plan »

Lululemon is outlining…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

RES

RPC, Inc.

$12.90

0.19 (1.49%)

06:48
04/24/19
04/24
06:48
04/24/19
06:48
Hot Stocks
RPC, Inc. cuts quarterly dividend to 5c per share from 10c per share »

RPC, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 08

    May

  • 09

    May

  • 13

    Nov

BKU

BankUnited

$35.73

0.74 (2.11%)

06:48
04/24/19
04/24
06:48
04/24/19
06:48
Earnings
BankUnited reports Q1 EPS 65c, consensus 64c »

The net interest margin,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

SXC

SunCoke Energy

$8.67

0.14 (1.64%)

06:48
04/24/19
04/24
06:48
04/24/19
06:48
Earnings
SunCoke Energy reports Q1 EPS 15c, consensus 18c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

RES

RPC, Inc.

$12.90

0.19 (1.49%)

06:47
04/24/19
04/24
06:47
04/24/19
06:47
Earnings
RPC, Inc. reports Q1 EPS 0c, consensus 3c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 08

    May

  • 09

    May

  • 13

    Nov

DDAIF

Daimler AG

$0.00

(0.00%)

06:47
04/24/19
04/24
06:47
04/24/19
06:47
Conference/Events
Daimler AG management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

BIIB

Biogen

$229.89

1.15 (0.50%)

06:46
04/24/19
04/24
06:46
04/24/19
06:46
Hot Stocks
Biogen CEO 'deeply disappointed' with discontinuation of aducanumab for AD »

"Biogen delivered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 04

    May

  • 29

    May

BIIB

Biogen

$229.89

1.15 (0.50%)

06:46
04/24/19
04/24
06:46
04/24/19
06:46
Earnings
Biogen reports Q1 adjusted EPS $6.98, consensus $6.84 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 04

    May

  • 29

    May

AVY

Avery Dennison

$115.99

2.085 (1.83%)

06:46
04/24/19
04/24
06:46
04/24/19
06:46
Earnings
Breaking Earnings news story on Avery Dennison »

Avery Dennison backs FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 18

    May

CE

Celanese

$112.15

7.65 (7.32%)

06:45
04/24/19
04/24
06:45
04/24/19
06:45
Conference/Events
Celanese management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

AVY

Avery Dennison

$115.99

2.085 (1.83%)

06:45
04/24/19
04/24
06:45
04/24/19
06:45
Earnings
Avery Dennison reports Q1 adjusted EPS $1.48, consensus $1.45 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 18

    May

06:45
04/24/19
04/24
06:45
04/24/19
06:45
General news
Breaking General news story  »

Week of 4/19 MBA Mortgage…

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

06:44
04/24/19
04/24
06:44
04/24/19
06:44
Periodicals
Coinbase shutters Chicago office, lays off about 30 engineers, Forbes reports »

Coinbase is shuttering…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TFX

Teleflex

$280.05

5.46 (1.99%)

06:43
04/24/19
04/24
06:43
04/24/19
06:43
Downgrade
Teleflex rating change  »

Teleflex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 13

    Nov

CDXC

ChromaDex

$4.22

0.225 (5.63%)

06:41
04/24/19
04/24
06:41
04/24/19
06:41
Hot Stocks
ChromaDex signs Tru Niagen distribution partnership in Canada with WELL Health »

ChromaDex announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$35.88

0.95 (2.72%)

06:41
04/24/19
04/24
06:41
04/24/19
06:41
Earnings
Boston Scientific narrows FY19 adj. EPS view to $1.54-$1.58 from $1.53-$1.58 »

Consensus $1.56. Narrows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 18

    May

  • 20

    May

  • 29

    May

  • 26

    Jun

  • 13

    Nov

TSEM

TowerJazz

$17.73

0.28 (1.60%)

06:40
04/24/19
04/24
06:40
04/24/19
06:40
Downgrade
TowerJazz rating change  »

Credit Suisse downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 28

    May

ZBH

Zimmer Biomet

$122.76

1.64 (1.35%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Upgrade
Zimmer Biomet rating change  »

Zimmer Biomet upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 10

    May

NOC

Northrop Grumman

$292.59

9.73 (3.44%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Hot Stocks
Northrop Grumman CEO says 'captured substantial new awards' in Q1 »

"In first quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

  • 29

    May

CPF

Central Pacific

$29.52

0.62 (2.15%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Earnings
Central Pacific reports Q1 EPS 55c, consensus 50c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 26

    Apr

RCKT

Rocket Pharmaceuticals

$19.32

1.54 (8.66%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Conference/Events
Rocket Pharmaceuticals management to meet with Evercore ISI »

Luncheon with Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

NOC

Northrop Grumman

$292.59

9.73 (3.44%)

06:38
04/24/19
04/24
06:38
04/24/19
06:38
Earnings
Northrop Grumman raises FY19 adj. EPS view to $18.90-$19.30 from $18.50-$19.00 »

FY19 consensus $18.96.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

  • 29

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.